Kenvue Inc. $KVUE Holdings Lowered by Cardinal Point Capital Management ULC

Cardinal Point Capital Management ULC cut its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 15.3% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 257,127 shares of the company’s stock after selling 46,563 shares during the quarter. Cardinal Point Capital Management ULC’s holdings in Kenvue were worth $4,433,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Kenvue in the second quarter valued at about $6,528,000. Jump Financial LLC lifted its position in Kenvue by 210.6% during the 2nd quarter. Jump Financial LLC now owns 54,823 shares of the company’s stock worth $1,147,000 after buying an additional 37,170 shares in the last quarter. AXA S.A. lifted its holdings in Kenvue by 21.1% during the 2nd quarter. AXA S.A. now owns 48,892 shares of the company’s stock worth $1,023,000 after buying an additional 8,524 shares in the last quarter. NewEdge Advisors LLC lifted its stake in shares of Kenvue by 219.1% during the second quarter. NewEdge Advisors LLC now owns 97,481 shares of the company’s stock valued at $2,040,000 after acquiring an additional 66,930 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its stake in Kenvue by 0.6% in the second quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company’s stock valued at $39,217,000 after acquiring an additional 10,885 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Insider Buying and Selling

In other news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.59% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on KVUE shares. Argus raised shares of Kenvue to a “hold” rating in a report on Friday, March 6th. Barclays cut their price objective on Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 14th. Citigroup lowered their target price on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Zacks Research upgraded shares of Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, May 8th. Finally, UBS Group dropped their price objective on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a report on Tuesday, April 7th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Kenvue has a consensus rating of “Hold” and an average price target of $19.33.

Kenvue Price Performance

Shares of KVUE opened at $18.77 on Thursday. The stock has a market capitalization of $36.05 billion, a P/E ratio of 22.09, a P/E/G ratio of 1.40 and a beta of 0.54. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $22.87. The company has a 50 day moving average of $17.60 and a 200-day moving average of $17.61. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The company had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $3.84 billion. During the same period last year, the company earned $0.24 earnings per share. The firm’s revenue was up 4.5% compared to the same quarter last year. As a group, equities research analysts forecast that Kenvue Inc. will post 1.16 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were given a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, May 13th. This represents a $0.83 annualized dividend and a yield of 4.4%. Kenvue’s payout ratio is 97.65%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.